
    
      patients undergoing mastectomy with axillary evacuation will be divided to four groups,
      Placebo group: received placebo capsule Duloxetine 30: received duloxetine 30 mg capsule
      Duloxetine 60: received duloxetine 60 mg capsule Duloxetine 90: received duloxetine 90 mg
      capsule the study medication is administered orall 2 h before surgery. Primary outcome
      variable: the first postoperative 24 h morphine consumption Secondary outcome: the VAS pain
      score measured every 4 h in the first 24 h postoperatively.
    
  